Objections to Johnson & Johnson's talc bankruptcy plan cite the U.S. Supreme Court's decision last year invalidating nonconsensual releases in Purdue Pharma's $6 billion opioid settlement.
A Department of Justice watchdog on Tuesday challenged a popular Texas bankruptcy court's practice of approving broad legal protections for a bankrupt company’s directors, officers and other ...